In a new strategic collaboration, Atinary Technologies is integrating its automated, no-code AI-driven process optimization technology with the state-of-the-art labs and process development capabilities of Snapdragon Chemistry to address the complex challenges of drug development. Thanks to the collaboration, the new customer from the US East Coast was already able to present impressive results..

在一项新的战略合作中，Atinary Technologies将其自动化、无代码人工智能驱动的过程优化技术与Snapdragon化学的最先进实验室和过程开发能力相结合，以应对药物开发的复杂挑战。由于合作，来自美国东海岸的新客户已经能够取得令人印象深刻的成果。。

Biopôle-based Atinary Technologies, whose leading no-code AI platform, SDLabsTM, and Self-Driving LabsTM technology are transforming research and development (R&D) of new molecules and chemicals, announces a strategic collaboration with Snapdragon Chemistry, a Cambrex company. Snapdragon is a recognized leader in active pharmaceutical ingredient (API) process development, with specialization in continuous flow process development, lab automation and complex synthetic APIs..

基于Biopôle的Atinary Technologies宣布与Cambrex公司Snapdragon Chemistry进行战略合作，该公司领先的无代码AI平台SDLabsTM和自动驱动LabsTM技术正在改变新分子和化学品的研发（R＆D）。Snapdragon是活性药物成分（API）工艺开发领域公认的领导者，专业从事连续流工艺开发、实验室自动化和复杂合成API。。

Through this collaboration, Snapdragon integrated its proprietary LabOSTM software platform with Atinary’s SDLabsTM platform to build a fully automated and AI-driven, medium-throughput Solid-Phase Oligonucleotide Synthesizer (SPOS) for the purpose of autonomous multi-objective process optimizations.

通过这次合作，Snapdragon将其专有的LabOSTM软件平台与Atinary的SDLabsTM平台集成在一起，构建了一个全自动化、人工智能驱动的中通量固相寡核苷酸合成器（SPOS），以实现自主多目标过程优化。

By using Atinary’s AI platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost compared to processes previously optimized by an experienced scientist..

通过使用Atinary的AI平台，Snapdragon的流程优化活动在测试应用程序中取得了重大改进，与之前由经验丰富的科学家优化的流程相比，产品产量提高了18%，成本降低了22%。。

'Atinary is committed to accelerating innovation and delivering cutting-edge solutions to our customers,' said Dr. Hermann Tribukait, Co-Founder and CEO of Atinary Technologies. 'Our work with Snapdragon showcases the power of our AI and data-driven process to solve complex chemistry and molecular discovery challenges in the pharmaceutical and biotech industry, orders of magnitude faster than traditional methods.'.

Atinary Technologies联合创始人兼首席执行官赫尔曼·特里布凯（HermannTribkait）博士说，Atinary致力于加速创新，为客户提供尖端解决方案。

Snapdragon’s state-of-the-art laboratories and process development capabilities, along with their ability to design and build self-contained reactors, will be instrumental in this collaboration.Promising first results

Snapdragon最先进的实验室和工艺开发能力，以及他们设计和建造自给式反应堆的能力，将有助于这一合作。有希望的初步结果

Contacted by Startupticker.ch, Edlyn Wu, Business Developer at Atinary, explains that the start-up’s East-Coast customer Snapdragon combined its LabOS software platform with Atinary's SDLabs platform to build its fully automated, AI-driven, mid-throughput solid-phase oligonucleotide synthesizer (SPOS).

Atinary的业务开发人员Edlyn Wu与Startupticker.ch联系后解释说，这家初创公司的东海岸客户Snapdragon将其LabOS软件平台与Atinary的SDLabs平台相结合，构建了其全自动、人工智能驱动的中吞吐量固相寡核苷酸合成器（SPOS）。

Through Atinary’s AI platform, Snapdragon’s process optimization campaign has demonstrated significant improvements across the tested applications, with up to an 18% increase in product yield and a 22% reduction in cost compared to processes previously optimized by an experienced scientist. Snapdragon also incorporates Atinary's platform into their R&D workflows, streamlining and expediting drug development pipelines and R&D portfolio. (PR - ES).

通过Atinary的AI平台，Snapdragon的流程优化活动在测试应用程序中取得了重大改进，与之前由经验丰富的科学家优化的流程相比，产品产量提高了18%，成本降低了22%。Snapdragon还将Atinary的平台纳入其研发工作流程，简化并加快了药物开发流程和研发组合。（公共关系）。

0Comments

0注意事项

Back to all news

返回所有新闻

Please login

请登录

or sign up

或注册

to comment.

发表评论。

Commenting guidelines

评论指南

Send

发送